Matches in SemOpenAlex for { <https://semopenalex.org/work/W2002687981> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W2002687981 endingPage "418" @default.
- W2002687981 startingPage "411" @default.
- W2002687981 abstract "Mink persistently infected with Aleutian disease virus (ADV) develop plasmacytosis (hypergammaglobulinaemia) and immune complex disease. Mink of different colour phases were infected with different strains of ADV and bled at different times after infection. The average antibody affinities (Kav) were measured in the sera and found to fall in the range of 2 X 10(9) - 2 X 10(10) M-1, thus indicating good-quality antibodies. In sera of non-Aleutian genotype mink a decline in Kav during development of plasmacytosis was observed. Moreover, the antibody heterogeneity (alpha values) tended to decrease during the disease progress. In contrast, the Kav values in sera of infected Aleutian genotype mink remained relatively high after hypergammaglobulinaemia developed, and the antibody heterogeneity for certain of the mink sera indicated restricted heterogeneity (high alpha values). In agreement with the clonal selection theory, low virus burden (for instance, during infection with a low-virulence ADV strain) generated relatively higher affinity antibodies than a high virus burden for instance, the highly virulent Utah I strain of ADV). Furthermore, antibodies present in low concentration were of higher affinity than antibodies present in high concentrations. The relatively high affinity antibodies found in this study indicate that if the immune complex disease seen in AD is caused by virus-anti-virus antibodies, good-quality antibodies are likely to be responsible for the pathological findings." @default.
- W2002687981 created "2016-06-24" @default.
- W2002687981 creator A5059887354 @default.
- W2002687981 creator A5075108470 @default.
- W2002687981 date "1984-05-01" @default.
- W2002687981 modified "2023-09-24" @default.
- W2002687981 title "Mink with Aleutian Disease Have High-Affinity Antiviral Antibodies" @default.
- W2002687981 cites W1233195445 @default.
- W2002687981 cites W1497296117 @default.
- W2002687981 cites W1587476167 @default.
- W2002687981 cites W1856032341 @default.
- W2002687981 cites W1902835161 @default.
- W2002687981 cites W1966870101 @default.
- W2002687981 cites W1969614777 @default.
- W2002687981 cites W2000769213 @default.
- W2002687981 cites W2034096173 @default.
- W2002687981 cites W2044577630 @default.
- W2002687981 cites W2052019985 @default.
- W2002687981 cites W2059300566 @default.
- W2002687981 cites W2070547658 @default.
- W2002687981 cites W2094819541 @default.
- W2002687981 cites W2111150251 @default.
- W2002687981 cites W2333358935 @default.
- W2002687981 cites W2484322941 @default.
- W2002687981 cites W3013285035 @default.
- W2002687981 cites W39793880 @default.
- W2002687981 doi "https://doi.org/10.1111/j.1365-3083.1984.tb00949.x" @default.
- W2002687981 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/6328642" @default.
- W2002687981 hasPublicationYear "1984" @default.
- W2002687981 type Work @default.
- W2002687981 sameAs 2002687981 @default.
- W2002687981 citedByCount "15" @default.
- W2002687981 countsByYear W20026879812015 @default.
- W2002687981 crossrefType "journal-article" @default.
- W2002687981 hasAuthorship W2002687981A5059887354 @default.
- W2002687981 hasAuthorship W2002687981A5075108470 @default.
- W2002687981 hasConcept C104317684 @default.
- W2002687981 hasConcept C159047783 @default.
- W2002687981 hasConcept C159654299 @default.
- W2002687981 hasConcept C18903297 @default.
- W2002687981 hasConcept C203014093 @default.
- W2002687981 hasConcept C2522874641 @default.
- W2002687981 hasConcept C2776364478 @default.
- W2002687981 hasConcept C2778709411 @default.
- W2002687981 hasConcept C2780754187 @default.
- W2002687981 hasConcept C55493867 @default.
- W2002687981 hasConcept C60987743 @default.
- W2002687981 hasConcept C86803240 @default.
- W2002687981 hasConcept C8891405 @default.
- W2002687981 hasConceptScore W2002687981C104317684 @default.
- W2002687981 hasConceptScore W2002687981C159047783 @default.
- W2002687981 hasConceptScore W2002687981C159654299 @default.
- W2002687981 hasConceptScore W2002687981C18903297 @default.
- W2002687981 hasConceptScore W2002687981C203014093 @default.
- W2002687981 hasConceptScore W2002687981C2522874641 @default.
- W2002687981 hasConceptScore W2002687981C2776364478 @default.
- W2002687981 hasConceptScore W2002687981C2778709411 @default.
- W2002687981 hasConceptScore W2002687981C2780754187 @default.
- W2002687981 hasConceptScore W2002687981C55493867 @default.
- W2002687981 hasConceptScore W2002687981C60987743 @default.
- W2002687981 hasConceptScore W2002687981C86803240 @default.
- W2002687981 hasConceptScore W2002687981C8891405 @default.
- W2002687981 hasIssue "5" @default.
- W2002687981 hasLocation W20026879811 @default.
- W2002687981 hasLocation W20026879812 @default.
- W2002687981 hasOpenAccess W2002687981 @default.
- W2002687981 hasPrimaryLocation W20026879811 @default.
- W2002687981 hasRelatedWork W2002687981 @default.
- W2002687981 hasRelatedWork W2035643332 @default.
- W2002687981 hasRelatedWork W2053489723 @default.
- W2002687981 hasRelatedWork W2061872883 @default.
- W2002687981 hasRelatedWork W2086778880 @default.
- W2002687981 hasRelatedWork W2159527899 @default.
- W2002687981 hasRelatedWork W2349061742 @default.
- W2002687981 hasRelatedWork W2990482023 @default.
- W2002687981 hasRelatedWork W3045355607 @default.
- W2002687981 hasRelatedWork W30612849 @default.
- W2002687981 hasVolume "19" @default.
- W2002687981 isParatext "false" @default.
- W2002687981 isRetracted "false" @default.
- W2002687981 magId "2002687981" @default.
- W2002687981 workType "article" @default.